Maher Albitar

26.1k total citations · 7 hit papers
342 papers, 20.0k citations indexed

About

Maher Albitar is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Maher Albitar has authored 342 papers receiving a total of 20.0k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Hematology, 155 papers in Genetics and 125 papers in Molecular Biology. Recurrent topics in Maher Albitar's work include Chronic Lymphocytic Leukemia Research (108 papers), Acute Myeloid Leukemia Research (97 papers) and Chronic Myeloid Leukemia Treatments (71 papers). Maher Albitar is often cited by papers focused on Chronic Lymphocytic Leukemia Research (108 papers), Acute Myeloid Leukemia Research (97 papers) and Chronic Myeloid Leukemia Treatments (71 papers). Maher Albitar collaborates with scholars based in United States, Germany and United Kingdom. Maher Albitar's co-authors include Hagop M. Kantarjian, Michael J. Keating, Francis J. Giles, Elihu H. Estey, Jörge E. Cortes, Susan O’Brien, Deborah A. Thomas, Taghi Manshouri, Zeev Estrov and Charles Koller and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Maher Albitar

335 papers receiving 19.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decitabine improves patient outcomes in myelodysplastic syndromes

2006 1.1k citations Hagop M. Kantarjian, Maher Albitar et al. Cancer profile →
Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

2006 970 citations Hagop M. Kantarjian, Francis J. Giles et al. profile →
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

1997 909 citations Elihu H. Estey, Maher Albitar et al. Blood profile →
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

2002 707 citations Michael J. Keating, Maher Albitar et al. Blood profile →
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

2005 704 citations Michael J. Keating, Susan O’Brien et al. Journal of Clinical Oncology profile →
Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells

2002 611 citations Maher Albitar, Zeev Estrov et al. profile →
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

2000 559 citations Hagop M. Kantarjian, Taghi Manshouri et al. Blood profile →

Peers

Countries citing papers authored by Maher Albitar

Since Specialization

Citations

This map shows the geographic impact of Maher Albitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher Albitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher Albitar more than expected).

Fields of papers citing papers by Maher Albitar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maher Albitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher Albitar. The network helps show where Maher Albitar may publish in the future.

Co-authorship network of co-authors of Maher Albitar

This figure shows the co-authorship network connecting the top 25 collaborators of Maher Albitar. A scholar is included among the top collaborators of Maher Albitar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maher Albitar. Maher Albitar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men 2025 ·Scandinavian Journal of Urology ·Torben Brøchner Pedersen, Mads Hvid Poulsen, (unknown), Søren Feddersen, Maher Albitar, Charlotte Aaberg Poulsen, Lars Lund	1
2	Peripheral Blood Tumor Associated Cell-Free DNA Testing as a Predictor for Relapse Postallogeneic Stem Cell Transplant for Acute Myelogenous Leukemia 2025 ·Transplantation and Cellular Therapy ·(unknown), Maciej Kabat, Andrew Ip, (unknown), Hyung C. Suh, Christina Cho, David H. Vesole, Michèle L. Donato, Maher Albitar, Scott D. Rowley	0
3	Using cell-free RNA in monitoring immune system and the demonstration of significant systemic deficiency in lymphoid and myeloid biomarkers in patients with cancer. 2024 ·Journal of Clinical Oncology ·Maher Albitar, (unknown), (unknown), Andrew Ip, Sally Agersborg, Arash Mohtashamian, David S. Siegel, Stanley E. Waintraub, Martin Gutierrez, Andrew L. Pecora, André Goy	1
4	Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model 2020 ·Journal of Clinical Oncology ·Inhye E. Ahn, Xin Tian, David Ipe, Mei Cheng, Maher Albitar, L. Claire Tsao, Lei Zhang, Wanlong Ma, Sarah E.M. Herman, Erika M. Gaglione, Susan Soto, James P. Dean, Adrian Wiestner	56
5	Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias 2020 ·Blood Advances ·Xing Fan, Ronan Desmond, Thomas Winkler, David J. Young, Bogdan Dumitriu, Danielle M. Townsley, Fernanda Gutierrez‐Rodrigues, Jennifer Lotter, Janet Valdez, Stephanie Sellers, (unknown), Ruba Shalhoub, Colin O. Wu, Maher Albitar, Katherine R. Calvo, Neal S. Young, Cynthia E. Dunbar	32
6	Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome 2016 ·Genetic Testing and Molecular Biomarkers ·(unknown), Wanlong Ma, (unknown), (unknown), Sally Agersborg, Maya Thangavelu, (unknown), Maher Albitar	9
7	Diagnostic and Prognostic Scoring System for Prostate Cancer Using Urine and Plasma Biomarkers 2014 ·Genetic Testing and Molecular Biomarkers ·Wanlong Ma, (unknown), Herbert A. Fritsche, Neal D. Shore, Maher Albitar	17
8	Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens. 2011 ·Archives of Pathology & Laboratory Medicine ·Aziza Nassar, Cynthia Cohen, Sally Agersborg, (unknown), Kathleen Lynch, Maher Albitar, Edward A. Barker, (unknown), (unknown), Eugene R. Heyman, (unknown), (unknown), Momin T. Siddiqui	22
9	Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study 2011 ·British Journal of Haematology ·Paul G. Richardson, Asher Chanan‐Khan, Sagar Lonial, Amrita Krishnan, Michael P. Carroll, Melissa Alsina, Maher Albitar, David M. Berman, Marianne Messina, Kenneth C. Anderson	78
10	Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose‐escalation study 2010 ·British Journal of Haematology ·Paul G. Richardson, Asher Chanan‐Khan, Melissa Alsina, Maher Albitar, David M. Berman, Marianne Messina, Constantine S. Mitsiades, Kenneth C. Anderson	60
11	Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome 2010 ·BMC Medical Genetics ·Wanlong Ma, Hagop M. Kantarjian, Ke Zhang, Xi Zhang, Xiuqiang Wang, (unknown), Amber C. Donahue, Zhong Zhang, Chen-Hsiung Yeh, Susan O’Brien, Guillermo Garcia‐Manero, Neil E. Caporaso, Ola Landgren, Maher Albitar	15
12	Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-Stage Myelodysplastic Syndrome 2009 ·Clinical Cancer Research ·Wanlong Ma, Hagop M. Kantarjian, B. Nebiyou Bekele, Amber C. Donahue, Xi Zhang, (unknown), Susan O’Brien, Elihu H. Estey, Zeev Estrov, Jörge E. Cortes, Michael J. Keating, Francis J. Giles, Maher Albitar	40
13	Response:Plasma and JAK2 mutation 2009 ·Blood ·Maher Albitar, Wanlong Ma, Hagop Kantarjian, Francis J. Giles	7
14	A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry 2007 ·Leukemia & lymphoma ·(unknown), Iman Jilani, M. Gorre, Hagop M. Kantarjian, Francis J. Giles, Alison L. Hannah, Maher Albitar	20
15	Proteomic‐based prediction of clinical behavior in adult acute lymphoblastic leukemia 2006 ·Cancer ·Maher Albitar, Steven J. Potts, Francis J. Giles, Susan O’Brien, Michael J. Keating, Deborah A. Thomas, Charlotte H. Clarke, Iman Jilani, Christine Aguilar, Elihu H. Estey, Hagop M. Kantarjian	25
16	Significance of FHIT expression in chronic myelogenous leukemia. 1999 ·PubMed ·H Kantarjian, Moshe Talpaz, Stephen J. O’Brien, Taghi Manshouri, Jörge E. Cortes, Frank Giles, Mary Beth Rios, C M Croce, Maher Albitar	9
17	Loss of FHIT expression in acute lymphoblastic leukemia. 1999 ·PubMed ·Cora Hallas, Maher Albitar, (unknown), M Keating, K Huebner, C M Croce	18
18	Acute lymphoblastic leukemia with myeloperoxidase activity 1996 ·American Journal of Hematology ·Susan Wright, (unknown), (unknown), Hagop M. Kantarjian, Michael A. Keating, Maher Albitar	1
19	Acute lymphoblastic leukemia with myeloperoxidase activity 1996 ·American Journal of Hematology ·Susan Wright, (unknown), (unknown), Hagop M. Kantarjian, Michael J. Keating, Maher Albitar	11
20	Human α-Globin Genes Demonstrate Autonomous Developmental Regulation in Transgenic Mice 1991 ·Molecular and Cellular Biology ·Maher Albitar, Makoto Katsumata, Stephen A. Liebhaber	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact